|
|
A clinical trial was conducted to determine the effect of low-dosage recombinant a-interferon
therapy in children with HBs Ag and HBe Ag positive chronic active hepatitis. Studied patients
consist of 7 biopsy-proven children (aged 6.5-11.5 yr). After 16 weeks of therapy, following results
were obtained.
Out of 7 HBe Ag positive cases, 5 cases (71.4%) were converted to HBe Ag negative state. One of
two... |
